How Urolithin A Protects the Gut—And Why Not Everyone Gets It

Key takeaways

• Researchers at the University of Louisville mapped how urolithin A, a compound made by gut bacteria, strengthens the intestinal barrier — increasing mucus production, reinforcing the lining, and boosting antimicrobial defenses.
• It works through the aryl hydrocarbon receptor in intestinal lining cells, which then activates the NLRP6 inflammasome — machinery usually associated with damaging inflammation.
• The same receptor can produce harmful or protective effects depending on where and how strongly it's activated, which resolves a longstanding puzzle in the field.
• A point worth knowing: urolithin A isn't present in food. Gut bacteria produce it, and not everyone's microbiome can.

The finding at the center of this study, published in Nature Communications by a team led by Venkatakrishna Rao Jala, is a reframe of something researchers thought they understood.

The aryl hydrocarbon receptor, or AHR, is a sensor that responds to signals from diet, environment, and gut microbes. Activated by certain environmental toxins, it drives harmful effects. Activated by beneficial dietary compounds, earlier work suggested it supports intestinal health. Nobody had fully explained why the same receptor produced opposite outcomes.

This study's answer: location and intensity. Urolithin A selectively activates AHR in intestinal epithelial cells — the specialized cells forming the gut lining — rather than broadly. In that specific context, AHR triggers the NLRP6 inflammasome, and rather than driving further inflammation, the system released measured amounts of molecules that repaired the lining, reinforced barrier integrity, increased protective mucus, and strengthened antimicrobial defense.

"The findings show that not all inflammatory pathways are harmful," said Sweta Ghosh, lead investigator on the study. "Under the right conditions and in the right cells, these pathways can play an essential role in maintaining gut health and supporting tissue repair."

Why the barrier matters

The intestinal lining does a difficult job: absorb nutrients while keeping bacteria and their byproducts out of circulation. It's a single cell layer covering an enormous surface area, and it replaces itself constantly.

When that barrier loosens, bacterial components reach the bloodstream and produce low-grade inflammatory signaling throughout the body. Barrier function tends to weaken gradually with age, independent of any specific condition — which makes the machinery that maintains it directly relevant to how well the rest of the system holds up over decades.

What's notable about the urolithin A mechanism is that it supports the barrier's own maintenance program rather than suppressing inflammation from outside. As Jala framed it, the goal would be "to restore intestinal balance instead of broadly suppressing immune responses."

The part that gets lost

Coverage of this compound almost always says it comes from pomegranates, walnuts, and berries. That's not entirely right—those foods contain ellagitannins. Gut bacteria convert ellagitannins into urolithin A. The compound itself is not in the food — it's produced downstream, and only if the right microbes are present to do the work.

Established research on this pathway has found conversion capacity varies substantially between individuals, and a considerable share of people produce little urolithin A even with consistent intake of the source foods. Two people can eat identical amounts of pomegranate and end up with very different circulating levels, because the determining factor is the microbiome, not the diet.

This is the same principle that keeps recurring across nutrition research. The molecule that matters is often not the one on the label — form, conversion, and delivery determine whether a compound reaches the tissue where it acts.

A longevity lens

Two ideas here transfer beyond the gut.

The first is that the body's inflammatory systems are dual-purpose. The same inflammasome machinery that drives damage in one context conducts tissue maintenance in another. That argues for thinking about inflammatory tone and context rather than treating inflammation as uniformly bad and something to blunt wherever found.

The second is that the microbiome functions as a metabolic intermediary. A meaningful portion of what diet actually does to the body happens through microbial conversion, which means the composition of the gut community partly determines what any given food is worth to a given person. That's a real source of individual variation, and it's one of the better arguments for supporting microbial diversity through fiber and plant variety.

The takeaway

This is mechanistic work — cell studies, organoid models, and human intestinal tissue samples. The pathway was confirmed in human tissue, which is a meaningful step above animal-only evidence, but no one has yet run a trial showing that raising urolithin A improves barrier function in healthy people over time.

What the study does well is explain how a microbially produced compound cooperates with the body's own response systems to maintain a tissue under constant turnover. And it clarifies why source foods alone may not deliver the compound reliably — which is genuinely worth knowing before assuming a handful of walnuts covers it.

References:

Sweta Ghosh, Zachary M. Vanwinkle, Sobha Rani Bodduluri, Subir Kumar Juin, Mahendar Kadari, Ankita Singh, Gerald W. Dryden, Matthew B. Lawrenz, Thirumala-Devi Kanneganti, Shesh N. Rai, Misty Good, Pawan Kumar, Bodduluri Haribabu, Venkatakrishna Rao Jala. Urolithin A activates aryl hydrocarbon receptor-NLRP6-mediated pathways in intestinal epithelial cells to modulate mucosal immunity and strengthen gut barrier integrity. Nature Communications, 2026; 17(1). DOI: 10.1038/s41467-026-73760-3.